Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Direct | Direct |
| Fund house | SBI | Axis |
| NAV | ₹19.8578 | ₹21.7858 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 4.1 years | 4.6 years |
| Expense ratio | 0.5% | 0.3% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 56.40 | 70.80 |
Returns
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| 1 month | +5.93% | +6.75% |
| 3 months | −2.63% | −2.18% |
| 6 months | +1.64% | +2.51% |
| YTD | +2.54% | +3.97% |
| 1 year | +1.91% | +3.24% |
| 3 years (CAGR) | +13.64% | +14.68% |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | +17.99% | +18.24% |
Risk
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Volatility | 18.3% | 18.7% |
| Downside volatility | 12.5% | 12.6% |
| Sharpe | 0.39 | 0.44 |
| Sortino | 0.57 | 0.65 |
| Calmar | 0.65 | 0.72 |
| Return / risk | 0.74 | 0.78 |
| Deepest fall | −21.10% | −20.27% |
| Days to recover | 262 | 243 |
| Below its high | −3.26% | −3.19% |
Against benchmark
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Alpha | −0.20% | — |
| Beta | 1.00 | — |
| R² | 100.0% | — |
| Up capture | 99.7% | — |
| Down capture | 100.5% | — |
| Tracking error | 0.1% | — |
| Information ratio | −2.34 | — |
| Treynor | 0.06 | — |
Consistency
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Best 1-year | +61.51% | +65.35% |
| Middle 1-year | +11.18% | +15.55% |
| Worst 1-year | −6.17% | −5.91% |
| 1-year periods with a loss | 9.4% | 7.1% |
| Middle 3-year | +21.69% | +23.94% |
| Positive months | 66.7% | 66.7% |
| Best day | +3.96% | +4.98% |
| Worst day | −7.11% | −7.71% |
| Worst 5% day | −1.97% | −1.96% |
| Positive days | 56.3% | 55.2% |
| NAVs a year | 252 | 251 |
SIP of ₹10,000 a month
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | +7.66% | +9.46% |
| 1-year XIRR | +5.87% | +8.23% |
Holdings overlap i
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| SBI Nifty Midcap 150 Index Fund | — | 53% |
| Axis Nifty Midcap 50 Index Fund | 53% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund |
|---|---|---|
| Laurus Labs Limited | 2.40% | 4.49% |
| The Federal Bank Limited | 2.15% | 4.02% |
| Multi Commodity Exchange of India Limited | 2.08% | 3.90% |
| The Indian Hotels Company Limited | 1.82% | 3.42% |
| One 97 Communications Limited | 1.80% | 3.37% |
| Hero MotoCorp Limited | 1.72% | 3.22% |
| Persistent Systems Limited | 1.68% | 3.15% |
| Bharat Heavy Electricals Limited | 1.45% | 2.71% |
| IndusInd Bank Limited | 1.41% | 2.65% |
| AU Small Finance Bank Limited | 1.29% | 2.41% |
| Ge Vernova T&D India Limited | 1.27% | 2.39% |
| Lupin Limited | 1.25% | 2.34% |
| Indus Towers Limited | 1.25% | 2.34% |
| IDFC First Bank Limited | 1.22% | 2.29% |
| FSN E-Commerce Ventures Limited | 1.22% | 2.29% |
| Bharat Forge Limited | 1.22% | 2.29% |
| Aurobindo Pharma Limited | 1.19% | 2.23% |
| Info Edge (India) Limited | 1.18% | 2.21% |
| Dixon Technologies (India) Limited | 1.17% | 2.20% |
| Marico Limited | 1.09% | 2.03% |
| Suzlon Energy Limited | 1.06% | 1.98% |
| Ashok Leyland Limited | 1.06% | 1.99% |
| Fortis Healthcare Limited | 1.02% | 1.92% |
| United Spirits Limited | 1.01% | 1.89% |
| APL Apollo Tubes Limited | 1.01% | 1.89% |
Sectors and company size
| SBI Nifty Midcap 150 Index Fund | Axis Nifty Midcap 50 Index Fund | |
|---|---|---|
| Large companies | 5.8% | 5.1% |
| Mid companies | 91.7% | 95.0% |
| Small companies | 2.5% | — |
| Top 10 holdings | 18.3% | 33.3% |
| Largest sector | Pharmaceuticals & Biotechnology 10% | Banks 13% |